HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaharu Seno Selected Research

Conditioned Culture Media

10/2022The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells.
1/2022The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
10/2021MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway.
4/2021An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane.
1/2021Microenvironment of mammary fat pads affected the characteristics of the tumors derived from the induced cancer stem cells.
12/2020Tumor-associated macrophages derived from cancer stem cells.
8/2020Metastasis Model of Cancer Stem Cell-Derived Tumors.
8/2020Cancer stem cell generation by silenced MAPK enhancing PI3K/AKT signaling.
1/2020Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
9/2019Cancer stem cell induction from mouse embryonic stem cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaharu Seno Research Topics

Disease

62Neoplasms (Cancer)
10/2022 - 04/2002
6Carcinoma (Carcinomatosis)
10/2022 - 08/2003
6Glioma (Gliomas)
02/2019 - 03/2009
5Lewis Lung Carcinoma
10/2021 - 01/2012
4Inflammation (Inflammations)
01/2022 - 12/2013
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2013
4Ovarian Neoplasms (Ovarian Cancer)
02/2019 - 07/2008
4Glioblastoma (Glioblastoma Multiforme)
02/2019 - 09/2007
3Carcinogenesis
02/2021 - 02/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 01/2014
3Hepatocellular Carcinoma (Hepatoma)
01/2012 - 08/2003
3Hyperglycemia
08/2008 - 09/2003
2Adenocarcinoma
06/2018 - 10/2006
2Telangiectasis (Telangiectasia)
02/2017 - 01/2016
2Meibomian Gland Dysfunction
02/2017 - 01/2016
2Lung Neoplasms (Lung Cancer)
01/2017 - 01/2014
2Brain Neoplasms (Brain Tumor)
03/2009 - 09/2007
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Triple Negative Breast Neoplasms
01/2021
1Neoplasm Metastasis (Metastasis)
08/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Teratoma (Teratoid Tumor)
01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2018
1Fibrosis (Cirrhosis)
10/2018

Drug/Important Bio-Agent (IBA)

21Conditioned Culture MediaIBA
10/2022 - 10/2007
15Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
12Pharmaceutical PreparationsIBA
04/2022 - 06/2004
9Epidermal Growth Factor (EGF)IBA
01/2022 - 04/2002
6Liposomes (Liposome)IBA
02/2019 - 03/2009
5ErbB Receptors (EGF Receptor)IBA
12/2013 - 09/2007
4LigandsIBA
12/2013 - 10/2007
3CytokinesIBA
01/2022 - 04/2018
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 12/2013
3Paclitaxel (Taxol)FDA LinkGeneric
05/2021 - 01/2013
3ChlorotoxinIBA
02/2018 - 01/2012
3Peptides (Polypeptides)IBA
02/2018 - 08/2003
3Eosinophil Cationic ProteinIBA
12/2013 - 11/2002
3NanocapsulesIBA
01/2013 - 04/2007
3Streptozocin (Streptozotocin)FDA Link
08/2008 - 06/2004
3Ribonucleases (Ribonuclease)IBA
12/2006 - 08/2002
2ChemokinesIBA
01/2022 - 08/2020
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2021 - 12/2006
2AntibodiesIBA
12/2020 - 03/2009
2VimentinIBA
08/2019 - 11/2004
2DNA (Deoxyribonucleic Acid)IBA
02/2019 - 06/2018
2Antineoplastic Agents (Antineoplastics)IBA
04/2018 - 01/2013
2Immunoglobulin G (IgG)IBA
02/2018 - 01/2012
2ToothpastesIBA
02/2017 - 01/2016
2Ophthalmic Solutions (Eye Drops)IBA
02/2017 - 01/2016
2Thalidomide (Thalomid)FDA Link
01/2017 - 08/2014
2Trastuzumab (Herceptin)FDA Link
01/2014 - 01/2013
2Biological ProductsIBA
12/2013 - 10/2007
2Indicators and Reagents (Reagents)IBA
01/2013 - 03/2010
2Monoclonal AntibodiesIBA
03/2010 - 03/2009
2Fluorescent Dyes (Fluorescent Probes)IBA
03/2010 - 08/2003
2beta CateninIBA
09/2008 - 11/2004
1diphenyleneiodoniumIBA
04/2022
1NADPH Oxidases (NAD(P)H oxidase)IBA
04/2022
1Nucleic AcidsIBA
01/2022
1InterleukinsIBA
01/2022
1AZD 6244IBA
10/2021
1mirdametinibIBA
10/2021
12- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- olIBA
10/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2021
1Metformin (Glucophage)FDA LinkGeneric
10/2021
1Immune Checkpoint InhibitorsIBA
05/2021
1AntigensIBA
05/2021
1Sorafenib (BAY 43-9006)FDA Link
04/2021
1Prolactin Receptors (Prolactin Receptor)IBA
01/2021
1Keratin-8 (Keratin 8)IBA
01/2021
1Estrogen ReceptorsIBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
01/2021
1Insulin (Novolin)FDA Link
01/2020
1IronIBA
02/2019
1Chelating AgentsIBA
02/2019
1SolutionsIBA
02/2019
1GoldIBA
02/2019
1calf thymus DNAIBA
02/2019
1acid gold tetrachlorideIBA
02/2019
1Colloids (Colloid)IBA
02/2019
1Drug CarriersIBA
02/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2018
1Biomarkers (Surrogate Marker)IBA
10/2018
1Alanine Transaminase (SGPT)IBA
10/2018
1Ferritins (Ferritin)IBA
10/2018
1LipopolysaccharidesIBA
04/2018
1Interferon-gamma (Interferon, gamma)IBA
04/2018
1Mannose ReceptorIBA
04/2018
1Interleukin-18 (Interleukin 18)IBA
04/2018

Therapy/Procedure

17Therapeutics
01/2022 - 07/2008
5Transplantation
01/2021 - 06/2004
3Drug Therapy (Chemotherapy)
04/2022 - 11/2014
2Radiotherapy
09/2019 - 02/2019
2Intravenous Injections
07/2017 - 08/2003
2Slit Lamp
02/2017 - 01/2016
1Immunotherapy
05/2021
1Hematopoietic Stem Cell Transplantation
11/2018
1Subcutaneous Injections
06/2018